These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 199093)
21. The equine immune response to equine herpesvirus-1: the virus and its vaccines. Kydd JH; Townsend HG; Hannant D Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492 [TBL] [Abstract][Full Text] [Related]
22. EHV-1 and EHV-4 infection in vaccinated mares and their foals. Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181 [TBL] [Abstract][Full Text] [Related]
23. Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1. Dutta SK; Myrup A; Bumgardner MK Am J Vet Res; 1980 Dec; 41(12):2066-8. PubMed ID: 6259978 [TBL] [Abstract][Full Text] [Related]
24. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract. Breathnach CC; Yeargan MR; Timoney JF; Allen GP Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871 [TBL] [Abstract][Full Text] [Related]
25. [Creation of an avirulent and immunogenic mutant from the rhinopneumonitis virus]. Tatarov G; Dilovski M Vet Med Nauki; 1986; 23(7):33-40. PubMed ID: 3024389 [TBL] [Abstract][Full Text] [Related]
26. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance. van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872 [TBL] [Abstract][Full Text] [Related]
27. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215 [TBL] [Abstract][Full Text] [Related]
28. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture. Eaglesome MD; Henry JN; McKnight JD Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261 [TBL] [Abstract][Full Text] [Related]
29. A new field strain of equine abortion virus (equine herpesvirus-1) among Kentucky horses. Allen GP; Yeargan MR; Turtinen LW; Bryans JT Am J Vet Res; 1985 Jan; 46(1):138-40. PubMed ID: 2982294 [TBL] [Abstract][Full Text] [Related]
31. Genomic and antigenic comparison of an equine herpesvirus 1 (EHV 1) isolate from the 1983 Lippizan abortion storm with EHV 1 reference strains. Engels M; Nowotny N; Metzler AE; Wyler R; Bürki F Microbiologica; 1986 Apr; 9(2):221-34. PubMed ID: 3012290 [TBL] [Abstract][Full Text] [Related]
32. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852 [TBL] [Abstract][Full Text] [Related]
33. Pathogenicity of equine herpesvirus 1 subtype 2 for foals and adult pony mares. Coignoul FL; Bertram TA; Cheville NF Vet Microbiol; 1984 Oct; 9(6):533-42. PubMed ID: 6095515 [TBL] [Abstract][Full Text] [Related]
34. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488 [TBL] [Abstract][Full Text] [Related]
35. Use of polarised equine endothelial cell cultures and an in vitro thrombosis model for potential characterisation of EHV-1 strain variation. Chiam R; Smid L; Kydd JH; Smith KC; Platt A; Davis-Poynter NJ Vet Microbiol; 2006 Mar; 113(3-4):243-9. PubMed ID: 16338104 [TBL] [Abstract][Full Text] [Related]
36. Impact of equine herpesvirus type 1 (EHV-1) infection on the migration of monocytic cells through equine nasal mucosa. Baghi HB; Nauwynck HJ Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):321-9. PubMed ID: 25456193 [TBL] [Abstract][Full Text] [Related]
37. Expression of late viral proteins is restricted in nasal mucosal leucocytes but not in epithelial cells during early-stage equine herpes virus-1 infection. Gryspeerdt AC; Vandekerckhove AP; Baghi HB; Van de Walle GR; Nauwynck HJ Vet J; 2012 Aug; 193(2):576-8. PubMed ID: 22425309 [TBL] [Abstract][Full Text] [Related]
38. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection. Paillot R; Daly JM; Luce R; Montesso F; Davis-Poynter N; Hannant D; Kydd JH Dev Comp Immunol; 2007; 31(2):202-14. PubMed ID: 16824599 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469 [TBL] [Abstract][Full Text] [Related]
40. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse. Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]